ZVSA - ZyVersa Therapeutics, Inc.
0.6848
0.134 19.509%
Share volume: 66,602,192
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.55
0.13
0.24%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-15-2024 | 08-09-2024 | 11-14-2024 | 03-27-2025 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | |||
| Operating expenses | 2.827 M | 2.754 M | 2.270 M | 0.000 | |
| Selling general and admin | 2.314 M | 2.045 M | 1.834 M | 0.000 | |
| Research and development | 512.937 K | 709.049 K | 436.043 K | 0.000 | |
| Total expenses | 2.827 M | 2.754 M | 2.270 M | 0.000 | |
| -2.57% | -17.59% | -100.00% | |||
| Operating income | -2.827 M | -2.754 M | -2.270 M | 0.000 | |
| Ebit | 0.000 | 0.000 | 0.000 | 0.000 | |
| Pretax income | -2.827 M | -2.754 M | -2.401 M | 0.000 | |
| -2.57% | -12.81% | -100.00% | |||
| Income tax | 0.000 | 9.707 K | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.827 M | -2.764 M | -2.401 M | 0.000 | |
| 2.23% | 13.12% | 100.00% |
